Equity (Details Narrative) - USD ($) |
1 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|
Jan. 15, 2025 |
May 31, 2023 |
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Number of Options Granted | 400,000 | |||
| Weighted Average Exercise Prices granted | $ 11.50 | |||
| Stock-based compensation | $ 1,505,244 | $ 0 | ||
| Common Shares Authorized | 200,000,000 | 200,000,000 | ||
| Intrinsic value | $ 1,454,148 | $ 1,958,047 | ||
| Issuance of common stock for cash, net of issuance costs, shares | 36,976 | |||
| Preferred Shares Authorized | 1,000,000 | 1,000,000 | ||
| Intrinsic Value Outstanding | $ 9,486,000 | $ 387,880 | ||
| Weighted average remaining term | 2 years 14 days | 8 months 8 days | ||
| 2026 [Member] | ||||
| Description of stock based compensation | Future stock-based compensation expense will be $138,641 for each of the first and second quarters of 2026, and $59,418 for each of the third and fourth quarters of 2026 | |||
| Stock Options [Member] | ||||
| Intrinsic value | $ 620,580 | $ 263,516 | ||
| Issuance of common stock for cash, net of issuance costs, shares | 1,225,600 | |||
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The maximum number of common shares permitted to be issued by an entity's charter and bylaws. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average period until annuitization or benefit payment is expected to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef
|
| X | ||||||||||
- Definition The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of noncash expense for share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Change in the weighted average exercise price of options outstanding. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|